Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: BW who wrote (5301)	7/9/2001 1:14:17 PM
From: Bucky Katt	Read Replies (1) \| Respond to of 48461

Yes, I am also on/in POCI, nice chart formation off of 1.50 I also like the forming chart of LOGC, insider buying, etc.... It is thinnnnnnn. Take a gander @DPW, mentioned before, has bounced back a bit, forming some nice looking lines, again, very thin, cheap, and if you think, as I do, that eventually buying will come into some of this beat to heck stuff, well.... ps, BPRX also a predictable trader, buy @ 6.50, sell around 7.00...wish I had kept the cheap shares.... FTEC has a bit of volume, but I don't like the chart.

To: BW who wrote (5301)	7/9/2001 3:45:26 PM
From: Bucky Katt	Read Replies (1) \| Respond to of 48461

MRBA moving up nice today. I started watching it a few months ago, waited like a sniper, went long a few shares last week, wanted to accumulate more on the cheap, up .70 on the day....so far You just never know...I remember seeing the ceo, Kim Polese, on the cover of Forbes a few years ago, and I thought wow, a nice looking smart girl...I always thought the valuation was a tad rich though.

To: BW who wrote (5301)	7/10/2001 9:10:12 AM
From: Bucky Katt	Respond to of 48461

LEON has some news today, along with TGEN & FONR> LION bioscience AG Launches New Software For Genome Research: SRS everEST(TM) SRS everEST(TM): Software for Clustering of Expressed Sequence Tags (ESTs) and Powerful Extension to LION's Suite of Solutions for Genome Research HEIDELBERG, Germany, July 10 /PRNewswire/ -- LION bioscience AG (Nasdaq: LEON, Neuer Markt: LIO, WKN 504 350) today announced the release of SRS everEST(TM) 1.0, its new complete transcript reconstruction software, which LION expects to be of great use in the discovery and analysis of genes. The new module will complement LION's Life Science Informatics platform as the basis for its i-biology® solution, which is being developed to reengineer and shorten the life science industry's product development cycle. LION has already sold SRS everEST(TM) to customers including Nestle SA and Intervet Innovation GmbH. ________________________________________________________ Founded in 1997, LION, together with its consolidated subsidiaries, has more than 465 employees, with headquarters in Heidelberg, Germany, and subsidiaries in Cambridge, UK, Cambridge, MA, USA and San Diego, CA, USA. To date, LION has established partnerships with leading life science companies, including Aventis, Bayer, Boehringer Ingelheim, Celera, DuPont, GlaxoSmithKline Wellcome, GMD, Janssen, Merck Inc., Nestle, Novartis, Paradigm Genetics, Pharmacia & Upjohn, Roche, Sumitomo Pharmaceuticals and Tripos.